Search research articles
Contact Us
Filters
Showing results (381-390 of 697) with videos related to
Page
of 70
Sort By:
American Journal of Human Genetics
|
September 18, 2025
Specifications of the ACMG/AMP variant curation guidelines for the analysis of germline PALB2 sequence variants
Marcy E Richardson, Megan F H Bishop, Megan A Holdren, et al.
Breast Cancer Research and Treatment
|
November 1, 2011
The postmenopausal hormone replacement therapy-related breast cancer risk is decreased in women carrying the CYP2C19*17 variant
Christina Justenhoven, Ofure Obazee, Stefan Winter, et al.
Current Oncology (Toronto, Ont.)
|
December 24, 2025
The Risk of Breast Cancer According to Mutation Type and Position in Carriers of a Pathogenic Variant in <i>BRCA1</i>
Joanne Kotsopoulos, Adriana I Apostol, Kelly Metcalfe, et al.
JAMA Oncology
|
February 29, 2024
Bilateral Oophorectomy and All-Cause Mortality in Women With BRCA1 and BRCA2 Sequence Variations
Joanne Kotsopoulos, Jacek Gronwald, Tomasz Huzarski, et al.
NPJ Digital Medicine
|
June 15, 2026
Deep learning analysis of breast cancer histology predicts ATM pathogenic variant carrier status
Nicolas M Viart, Lucie Thibault, Tristan Lazard, et al.
NPJ Breast Cancer
|
February 13, 2020
Folate receptor alpha expression associates with improved disease-free survival in triple negative breast cancer patients
Nadine Norton, Bahaaeldin Youssef, David W Hillman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 24, 2018
BRCA1/2 Mutations and Bevacizumab in the Neoadjuvant Treatment of Breast Cancer: Response and Prognosis Results in Patients With Triple-Negative Breast Cancer From the GeparQuinto Study
Peter A Fasching, Sibylle Loibl, Chunling Hu, et al.
Communications Biology
|
February 23, 2023
MacroH2A histone variants modulate enhancer activity to repress oncogenic programs and cellular reprogramming
Wazim Mohammed Ismail, Amelia Mazzone, Flavia G Ghiraldini, et al.
Journal of the National Cancer Institute
|
March 6, 2018
The Landscape of Somatic Genetic Alterations in Breast Cancers From ATM Germline Mutation Carriers
Britta Weigelt, Rui Bi, Rahul Kumar, et al.
JAMA
|
September 3, 2010
Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality
Susan M Domchek, Tara M Friebel, Christian F Singer, et al.
Page
of 70
Search research articles
Search
Showing results (381-390 of 697) with videos related to
Sort By:
Page
of 70
American Journal of Human Genetics
|
September 18, 2025
Specifications of the ACMG/AMP variant curation guidelines for the analysis of germline PALB2 sequence variants
Marcy E Richardson, Megan F H Bishop, Megan A Holdren, et al.
Breast Cancer Research and Treatment
|
November 1, 2011
The postmenopausal hormone replacement therapy-related breast cancer risk is decreased in women carrying the CYP2C19*17 variant
Christina Justenhoven, Ofure Obazee, Stefan Winter, et al.
Current Oncology (Toronto, Ont.)
|
December 24, 2025
The Risk of Breast Cancer According to Mutation Type and Position in Carriers of a Pathogenic Variant in <i>BRCA1</i>
Joanne Kotsopoulos, Adriana I Apostol, Kelly Metcalfe, et al.
JAMA Oncology
|
February 29, 2024
Bilateral Oophorectomy and All-Cause Mortality in Women With BRCA1 and BRCA2 Sequence Variations
Joanne Kotsopoulos, Jacek Gronwald, Tomasz Huzarski, et al.
NPJ Digital Medicine
|
June 15, 2026
Deep learning analysis of breast cancer histology predicts ATM pathogenic variant carrier status
Nicolas M Viart, Lucie Thibault, Tristan Lazard, et al.
NPJ Breast Cancer
|
February 13, 2020
Folate receptor alpha expression associates with improved disease-free survival in triple negative breast cancer patients
Nadine Norton, Bahaaeldin Youssef, David W Hillman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 24, 2018
BRCA1/2 Mutations and Bevacizumab in the Neoadjuvant Treatment of Breast Cancer: Response and Prognosis Results in Patients With Triple-Negative Breast Cancer From the GeparQuinto Study
Peter A Fasching, Sibylle Loibl, Chunling Hu, et al.
Communications Biology
|
February 23, 2023
MacroH2A histone variants modulate enhancer activity to repress oncogenic programs and cellular reprogramming
Wazim Mohammed Ismail, Amelia Mazzone, Flavia G Ghiraldini, et al.
Journal of the National Cancer Institute
|
March 6, 2018
The Landscape of Somatic Genetic Alterations in Breast Cancers From ATM Germline Mutation Carriers
Britta Weigelt, Rui Bi, Rahul Kumar, et al.
JAMA
|
September 3, 2010
Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality
Susan M Domchek, Tara M Friebel, Christian F Singer, et al.
Page
of 70